Michael McCaul purchased NBIX on August 14, 2023 | PolitAlpha
Michael McCaul purchased NBIX (Neurocrine Biosciences Inc) on Aug 14, 2023 with an estimated value between $15,000 and $50,000. This trade was filed under child. The stock is currently up 24.7% from the trade price.